15-51203633-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000559909.1(MIR4713HG):​n.195-74350A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.789 in 152,078 control chromosomes in the GnomAD database, including 47,473 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.79 ( 47473 hom., cov: 31)

Consequence

MIR4713HG
ENST00000559909.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.16

Publications

4 publications found
Variant links:
Genes affected
MIR4713HG (HGNC:53124): (MIR4713 host gene)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000559909.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.814 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000559909.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MIR4713HG
NR_146310.1
n.195-74350A>G
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MIR4713HG
ENST00000559909.1
TSL:4
n.195-74350A>G
intron
N/A
MIR4713HG
ENST00000805692.1
n.279-74350A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.789
AC:
119864
AN:
151960
Hom.:
47449
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.755
Gnomad AMI
AF:
0.721
Gnomad AMR
AF:
0.749
Gnomad ASJ
AF:
0.860
Gnomad EAS
AF:
0.693
Gnomad SAS
AF:
0.796
Gnomad FIN
AF:
0.804
Gnomad MID
AF:
0.858
Gnomad NFE
AF:
0.820
Gnomad OTH
AF:
0.776
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.789
AC:
119936
AN:
152078
Hom.:
47473
Cov.:
31
AF XY:
0.789
AC XY:
58636
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.755
AC:
31289
AN:
41452
American (AMR)
AF:
0.748
AC:
11428
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.860
AC:
2987
AN:
3472
East Asian (EAS)
AF:
0.693
AC:
3584
AN:
5170
South Asian (SAS)
AF:
0.797
AC:
3833
AN:
4812
European-Finnish (FIN)
AF:
0.804
AC:
8520
AN:
10594
Middle Eastern (MID)
AF:
0.861
AC:
253
AN:
294
European-Non Finnish (NFE)
AF:
0.820
AC:
55745
AN:
67976
Other (OTH)
AF:
0.775
AC:
1639
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1260
2520
3779
5039
6299
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
870
1740
2610
3480
4350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.809
Hom.:
111028
Bravo
AF:
0.781
Asia WGS
AF:
0.715
AC:
2488
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.77
DANN
Benign
0.40
PhyloP100
-1.2

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs934632;
hg19: chr15-51495830;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.